Trial · NCT01098097
Adverse events23
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 23
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Peginterferon Alpha and Ribavirin | 104 | 963 | 106 |
| other | Leucopenia | Blood and lymphatic system disorders | Peginterferon Alpha and Ribavirin | 52 | 963 | 55 |
| other | Neutropenia | Blood and lymphatic system disorders | Peginterferon Alpha and Ribavirin | 55 | 963 | 59 |
| other | Fatigue | General disorders | Peginterferon Alpha and Ribavirin | 49 | 963 | 49 |
| other | Pyrexia | General disorders | Peginterferon Alpha and Ribavirin | 54 | 963 | 59 |
| serious | Anemia | Blood and lymphatic system disorders | Peginterferon Alpha and Ribavirin | 3 | 963 | 3 |
| serious | Leucopenia | Blood and lymphatic system disorders | Peginterferon Alpha and Ribavirin | 1 | 963 | 1 |
| serious | Neutropenia | Blood and lymphatic system disorders | Peginterferon Alpha and Ribavirin | 3 | 963 | 3 |
| serious | Myocardial ischaemia | Cardiac disorders | Peginterferon Alpha and Ribavirin | 1 | 963 | 1 |
| serious | General physical health deterioration | General disorders | Peginterferon Alpha and Ribavirin | 1 | 963 | 1 |
| serious | Pyrexia | General disorders | Peginterferon Alpha and Ribavirin | 1 | 963 | 1 |
| serious | Acute tonsillitis | Infections and infestations | Peginterferon Alpha and Ribavirin | 1 | 963 | 1 |
| serious | Campylobacter infection | Infections and infestations | Peginterferon Alpha and Ribavirin | 1 | 963 | 1 |
| serious | Erysipelas | Infections and infestations | Peginterferon Alpha and Ribavirin | 1 | 963 | 1 |
| serious | Gastroenteritis | Infections and infestations | Peginterferon Alpha and Ribavirin | 1 | 963 | 1 |
| serious | Loss of consciousness | Nervous system disorders | Peginterferon Alpha and Ribavirin | 1 | 963 | 1 |
| serious | Parkinson's disease | Nervous system disorders | Peginterferon Alpha and Ribavirin | 1 | 963 | 1 |
| serious | Sciatica | Nervous system disorders | Peginterferon Alpha and Ribavirin | 1 | 963 | 1 |
| serious | Transient ischaemic attack | Nervous system disorders | Peginterferon Alpha and Ribavirin | 1 | 963 | 1 |
| serious | Anxiety | Psychiatric disorders | Peginterferon Alpha and Ribavirin | 1 | 963 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01098097/events